Pulmonx Stock

Pulmonx EPS

The Earnings per Share (EPS) of Pulmonx (LUNG) as of Aug 13, 2026 is -1.30 USD. In the previous year, Earnings per Share (EPS) was -1.44 USD — a change of -9.54% (higher).

EPS

-1.30USD

YoY

-9.54%

Last updated:

Earnings per Share (EPS) of Pulmonx is 2026 -1.30 USD. Earnings per Share (EPS) of Pulmonx was 2025 -1.44 USD. It decreases by -9.54% higher compared to the previous year.
Access this data via the Eulerpool API

Pulmonx Stock analysis

What does Pulmonx do? Pulmonx Corp is an innovative medical technology company based in the USA and Europe. The company specializes in the development of non-invasive solutions for the treatment of lung diseases. Pulmonx was founded in 1997 and has since introduced numerous groundbreaking technologies to the market that improve the quality of life for patients with chronic lung diseases. Pulmonx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pulmonx stock

Earnings per Share (EPS) of Pulmonx is -1.30 USD in 2026.

Earnings per Share (EPS) of Pulmonx changed from -1.44 USD to -1.30 USD, representing a -9.54% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Pulmonx since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

Income Statement — Pulmonx

All Key Metrics — Pulmonx